Bank of New York Mellon’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Bank of New York Mellon’s Portfolio BIOR Stock Details BIOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-226	Closed	-$7.43K	–	4509
2022 Q4	$7.43K	Hold	226	–	–	﹤0.01%	4435
2022 Q3	$27K	Hold	226	–	–	﹤0.01%	4413
2022 Q2	$40K	Hold	226	–	–	﹤0.01%	4392
2022 Q1	$65K	Hold	226	–	–	﹤0.01%	4488
2021 Q4	$118K	Buy	226 +170	+304%	+$122K	﹤0.01%	4380
2021 Q3	$21K	Hold	56	–	–	﹤0.01%	4504
2021 Q2	$50K	Sell	56 -107	-66%	-$81.8K	﹤0.01%	4328
2021 Q1	$193K	Buy	163 +96	+143%	+$132K	﹤0.01%	4067
2020 Q4	$89K	Buy	+67	New	+$98.3K	﹤0.01%	4090

Other funds holding BIOR

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Bank of New York Mellon's BIOR Position: Q1 2023 in Review

Bank of New York Mellon sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q1 2023, closing a stake of 226 shares — an estimated $7.43K sold.

Bank of New York Mellon first reported a position in BIOR in Q4 2020 and held it in 9 quarters. The position peaked at $193K in Q1 2021. 30 funds tracked by Wall St. Rank hold BIOR as of Q1 2023.

Bank of New York Mellon reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Bank of New York Mellon sold 226 Biora Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $7.43K.
Bank of New York Mellon first reported a position in Biora Therapeutics, Inc. Common Stock in Q4 2020 and held it in 9 quarters.
Bank of New York Mellon's Biora Therapeutics, Inc. Common Stock position peaked at $193K in Q1 2021.
30 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Bank of New York Mellon's 13F filing for Q1 2023, filed 9 May 2023.